On 4 December, our partner Aridhia announced that its digital research platform AnalytiXagility used in the health, biomedical research and precision medicine sectors, is to move all its work to Azure, including treatment studies by the European Prevention of Alzheimer’s Dementia Consortium (EPAD). Aridhia will use Microsoft’s service to offer medical experts, such as those at EPAD,…
This month, we get to know the Tayside centre behind EPAD. The site began recruiting in February 2018, with its first participant enrolled on 22nd February. The team has currently recruited 50 participants and still has 6 participants due in for baselines this month, taking the total to 56 participants by the end of November.…
What is your current role in EPAD? I am a brand-new member of the EPAD work package six. Having joined the Alzheimer’s team at Biogen in May 2018, the EPAD work was highlighted as a key coalition to join and support from a communications and advocacy perspective. I bring to the team over six years…
What is your current role in EPAD? I am the Global Trial Lead for the Proof of Concept Trial working in the Chief Investigator’s office at the University of Edinburgh. In this role I am responsible for bringing together the EPAD team at the University and IQVIA to work with intervention owners who wish to…
In October 2018, two articles about the EPAD project were published. On 29 October, the journal Dementia published an article entitled “Research participants as collaborators: Background, experience and policies from the PREVENT Dementia and EPAD programmes”. The article led by Sarah Gregory from the University of Edinburgh (UK) described how the PREVENT Dementia panel forms…
On 30 October, NHS Research Scotland organised its seventh NHS Research Scotland Annual Conference in Perth. The event brought together delegates across NHS, academia, industry and third sector under the theme “The impact of research then, now and in the future”. This year, organisers celebrate 70 years of the NHS. Through a series of plenary…
On 29-31 October, Alzheimer Europe held the 28th Alzheimer Europe Conference “Making dementia a European priority” in Barcelona (Spain). This year, the event gathered more than 800 participants from 46 countries including 35 people with dementia. The programme included 239 oral presentations and 175 poster presentations. We were glad to see our epadista Jose Luis…
On World Alzheimer’s Day, the members of the EPAD initiative have reached a new milestone where the EPAD Longitudinal Cohort Study (LCS) has screened more than 1,000 research participants. Within EPAD, the team at University Of Oxford (UOF) has been recruiting successfully and recruited the 1,000th participant. Dr Vanessa Raymont, principal investigator of the EPAD…
On 27 October, Professor Craig Ritchie gave a talk at the 11th Clinical Trials on Alzheimer’s Disease (CTAD) conference in Barcelona. The aim of the CTAD conference is to bring together global leaders in the treatment of Alzheimer’s disease to discuss the development of the next generation of Alzheimer’s disease treatments. For the first time,…
On 22-23 October, the Innovative Medicines Initiative (IMI) held a scientific symposium in Brussels (Belgium) to celebrate its 10th anniversary. Young researchers from IMI projects were invited to submit abstracts for IMI’s first scientific symposium to showcase the stellar science that IMI projects have been doing. The symposium featured 72 poster displays and 25 oral presentations that…
